凯悦酒店

最新新闻

• Top Performers in Hong Kong Stocks This Week | Baige Online surged over 27% for the week as its board of directors approved the full circulation of H-shares, involving the conversion of 170 million domestic shares; Benmo Technology rose more than 27% following a partnership with China Rare Earth Innovation to establish a full industry chain from rare earths to robotic power systems; Sunmi Technolo
  \u5e02\u573a\u8d44\u8baf · 2026/10/10
• 评级变动
  Shandong Gold Mining Co., Ltd. Class H (1787): New Sell Recommendation for This Basic Materials Giant
  TipRanks · 2026/10/10
• 评级变动
  J.P. Morgan Remains a Hold on Tianqi Lithium Corp. Class H (9696)
  TipRanks · 2026/10/10
• 公司公告
  H.I.S: In fiscal year 2026, selected as a "Company with Remarkable Improvements in Disclosure" in the "Selection of Excellent Disclosure Companies."
  JPX · 2026/10/9
• 评级变动
  Contemporary Amperex Technology Co., Limited Class H (3750) Gets a Buy From CLSA
  TipRanks · 2026/10/10
• 公司公告
  PGLOBE: CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED DISPOSAL BY PGB LANDMARK SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF PARAGON GLOBE BERHAD, OF 2 PARCELS OF FREEHOLD LANDS HELD UNDER H.S.(D) 646688, PTD 5868 (CURRENTLY KNOWN AS H.S.(D) 651854, PTD 12333) AND H.S.(D) 646687, PTD 5401 (CURRENTLY KNOWN AS H.S.(D) 651853, PTD 12334), IN THE MUKIM OF TANJUNG KUPANG, DISTRICT OF JOHOR BAHRU, STATE
  Bursa Malaysia · 2026/10/9
• 评级变动
  Contemporary Amperex Technology Co., Limited Class H (3750) Receives a Buy From Bernstein
  TipRanks · 2026/10/10
• Should You Be Adding C.H. Robinson Worldwide (NASDAQ:CHRW) To Your Watchlist Today?
  Simply Wall St · 2026/10/10
• 评级变动
  Citi Remains a Buy on Sigenergy Technology Co., Ltd. Class H (6656)
  TipRanks · 2026/10/10
• 公司公告
  H.B. Fuller | 8-K: Current report
  SEC · 2026/10/9
• 公司公告
  C.H. Robinson Worldwide | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  SEC · 2026/10/9
• 评级变动
  H.C. Wainwright Sticks to Their Buy Rating for Aligos Therapeutics (ALGS)
  TipRanks · 2026/10/9
• 评级变动
  H.C. Wainwright Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $100
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  H.C. Wainwright Maintains Aligos Therapeutics(ALGS.US) With Buy Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• New China Life Insurance continues to increase its holdings in Guotai Haitong H-shares, with its stake exceeding one-fifth.
  wallstreetcn · 2026/10/10
• 评级变动
  H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  H.C. Wainwright Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Maintains Target Price $620
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• H.C. Wainwright Downgrades Pacira BioSciences(PCRX.US) to Hold Rating, Cuts Target Price to $36.5
  \u5e02\u573a\u8d44\u8baf · 2026/10/10
• 公司公告
  908 Devices | 4: Statement of changes in beneficial ownership of securities-Officer Griffith Joseph H. IV
  SEC · 2026/10/9
• Guoxia Technology Co., Ltd. Class H (2655) Receives a Buy From CGS International
  TipRanks · 2026/10/10
• 评级变动
  H.C. Wainwright Maintains Q32 Bio(QTTB.US) With Buy Rating, Maintains Target Price $36
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• H.C. Wainwright Maintains Jade Biosciences(JBIO.US) With Buy Rating, Maintains Target Price $55
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Morgan Stanley Sticks to Its Buy Rating for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276)
  TipRanks · 2026/10/1
• H.C. Wainwright Keeps Their Buy Rating on TriSalus Life Sciences (TLSI)
  TipRanks · 2026/10/1
• 公司公告
  H.I.S: Report on the Status of Treasury Stock Purchases (pursuant to Article 24-6, Paragraph 1 of the Act)
  EDINET · 2026/10/1

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。